glimepiride has been researched along with Diabetes Mellitus in 19 studies
glimepiride: structure given in first source
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the pharmacokinetic characteristics of glimepiride and its metabolites in normal-weight and morbidly obese patients with type 2 diabetes to determine whether the pharmacokinetics of glimepiride are altered by obesity." | 5.11 | Glimepiride pharmacokinetics in obese versus non-obese diabetic patients. ( Chi, EM; Lehr, KH; Shukla, UA, 2004) |
| "Glimepiride and nateglinide are two common oral hypoglycemic agents currently being used with humans suffering from Type 2 diabetes mellitus." | 3.75 | Effect of glimepiride and nateglinide on serum insulin and glucose concentration in healthy cats. ( Arai, T; Honjo, T; Ishioka, K; Lee, P; Miki, Y; Mizutani, H; Mori, A; Nishimaki, Y; Oda, H; Saeki, K; Sako, T; Yamashita, T, 2009) |
| "Gatifloxacin, a commonly prescribed antimicrobial can produce profound hypoglycemia and disturbances in glucose homeostasis especially in diabetes patients on sulphonylureas." | 3.73 | Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride. ( Kesavadev, J; Rasheed, SA, 2006) |
| "Diabetes mellitus is a chronic metabolic disease which has an adverse impact on the quality of patient's life, so patients often need to receive treatment for a long time." | 3.01 | Analysis of pharmacoeconomic value of sitagliptin in the treatment of diabetes mellitus. ( Chen, FW; Hou, KJ; Khan, BA; Wu, Z; Wu, ZZ; Zhang, S, 2021) |
| " A dosage of 70/30 insulin before supper was titrated, seeking fasting capillary blood glucose (FBG) 120 mg/dl (6." | 2.69 | Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group. ( Riddle, MC; Schneider, J, 1998) |
| "Anti-diabetic drugs are used in the treatment of diabetes mellitus to control glucose levels in the blood." | 2.66 | Anti-diabetic drugs recent approaches and advancements. ( Dowarah, J; Singh, VP, 2020) |
| "The average glucose level at which hemiparesis developed was 1." | 2.48 | A case of hypoglycemic hemiparesis and literature review. ( Itoh, A; Itoh, H; Kawai, T; Meguro, S; Soeda, Y; Yoshino, T, 2012) |
| "Glimepiride, which is a more appropriate sulfonylurea, was suggested as an alternative at order entry." | 1.46 | Implementation and Assessment of an Ambulatory Prescribing Guidance Tool to Improve Patient Safety in the Geriatric Population. ( Bellone, JM; Ruhland, DJ; Wilkes, E, 2017) |
| " foenum-graecum seed when it was administered orally at high dose level (3 g/kg body weight), which is higher than effective antihyperglycemic dose, and closely observed for 24 hrs for any mortality and next 10 days for any delayed toxic effects on gross behavioral activities." | 1.35 | Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: a brief qualitative phytochemical and acute toxicity test on the extract. ( Ahmed, K; Alauddin, M; Mowla, A; Rahman, MA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, HB | 1 |
| Zhang, YA | 1 |
| Wu, GZ | 1 |
| Zhou, JP | 1 |
| Huang, WL | 1 |
| Hu, XW | 1 |
| Dowarah, J | 1 |
| Singh, VP | 1 |
| Wu, Z | 1 |
| Chen, FW | 1 |
| Wu, ZZ | 1 |
| Zhang, S | 1 |
| Khan, BA | 1 |
| Hou, KJ | 1 |
| Qin, X | 1 |
| Zhong, J | 1 |
| Lan, D | 1 |
| Ruhland, DJ | 1 |
| Bellone, JM | 1 |
| Wilkes, E | 1 |
| Tayek, J | 1 |
| Ye, Y | 1 |
| Lin, Y | 1 |
| Perez-Polo, JR | 1 |
| Birnbaum, Y | 1 |
| Mori, A | 1 |
| Lee, P | 1 |
| Yamashita, T | 1 |
| Nishimaki, Y | 1 |
| Oda, H | 1 |
| Saeki, K | 1 |
| Miki, Y | 1 |
| Mizutani, H | 1 |
| Ishioka, K | 1 |
| Honjo, T | 1 |
| Arai, T | 1 |
| Sako, T | 1 |
| Yadav, M | 1 |
| Lavania, A | 1 |
| Tomar, R | 1 |
| Prasad, GB | 1 |
| Jain, S | 1 |
| Yadav, H | 1 |
| Mowla, A | 1 |
| Alauddin, M | 1 |
| Rahman, MA | 1 |
| Ahmed, K | 1 |
| Andersson, C | 1 |
| Gislason, GH | 1 |
| Jørgensen, CH | 1 |
| Hansen, PR | 1 |
| Vaag, A | 1 |
| Sørensen, R | 1 |
| Mérie, C | 1 |
| Olesen, JB | 1 |
| Weeke, P | 1 |
| Schmiegelow, M | 1 |
| Norgaard, ML | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| Yoshino, T | 1 |
| Meguro, S | 1 |
| Soeda, Y | 1 |
| Itoh, A | 1 |
| Kawai, T | 1 |
| Itoh, H | 1 |
| Kim, JY | 1 |
| Kim, DW | 1 |
| Kuk, YM | 1 |
| Park, CW | 1 |
| Rhee, YS | 1 |
| Oh, TO | 1 |
| Weon, KY | 1 |
| Park, ES | 1 |
| Bleskestad, IH | 1 |
| Birkeland, KI | 1 |
| Mori, Y | 1 |
| Komiya, H | 1 |
| Kurokawa, N | 1 |
| Tajima, N | 1 |
| Shukla, UA | 1 |
| Chi, EM | 1 |
| Lehr, KH | 1 |
| Kesavadev, J | 1 |
| Rasheed, SA | 1 |
| Riddle, MC | 1 |
| Schneider, J | 1 |
| Doi, K | 1 |
2 reviews available for glimepiride and Diabetes Mellitus
| Article | Year |
|---|---|
Anti-diabetic drugs recent approaches and advancements.
Topics: Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Molecular Structur | 2020 |
A case of hypoglycemic hemiparesis and literature review.
Topics: Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus; Humans; Hypoglycemia; Male; Metformin; Pa | 2012 |
3 trials available for glimepiride and Diabetes Mellitus
| Article | Year |
|---|---|
Analysis of pharmacoeconomic value of sitagliptin in the treatment of diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Diabetes Mellitus; Economics, Pharmaceutical; | 2021 |
Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; | 2004 |
Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mell | 1998 |
14 other studies available for glimepiride and Diabetes Mellitus
| Article | Year |
|---|---|
Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents.
Topics: Adipocytes; Animals; Benzenesulfonamides; Biological Transport; Chemistry, Pharmaceutical; Diabetes | 2009 |
The use of glimepiride for the treatment of neonatal diabetes mellitus caused by a novel mutation of the
Topics: Diabetes Mellitus; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Male; Mutation; Prognosis; | 2020 |
Implementation and Assessment of an Ambulatory Prescribing Guidance Tool to Improve Patient Safety in the Geriatric Population.
Topics: Aged; Ambulatory Care; Decision Support Systems, Clinical; Diabetes Mellitus; Drug Interactions; Gly | 2017 |
SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.
Topics: ATP-Binding Cassette Transporters; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Potassium Cha | 2008 |
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Deca | 2008 |
Effect of glimepiride and nateglinide on serum insulin and glucose concentration in healthy cats.
Topics: Animals; Blood Glucose; Cat Diseases; Cats; Cyclohexanes; Diabetes Mellitus; Female; Glucose Toleran | 2009 |
Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats.
Topics: Animals; Blood Glucose; Cucurbitaceae; Diabetes Mellitus; Fruit; Gymnema sylvestre; Humans; Hypoglyc | 2010 |
Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: a brief qualitative phytochemical and acute toxicity test on the extract.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Do | 2009 |
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hyp | 2011 |
Investigation of an active film coating to prepare new fixed-dose combination tablets for treatment of diabetes.
Topics: Adult; Algorithms; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Diabetes Mellitu | 2012 |
[Differences between oral antidiabetics].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Glipizide; Humans; Hypoglycemic A | 2003 |
Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type | 2004 |
Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
Topics: Anti-Infective Agents; Blood Glucose; Diabetes Mellitus; Female; Fluoroquinolones; Gatifloxacin; Hom | 2006 |
[New oral antidiabetic agents].
Topics: Animals; Cyclohexanols; Diabetes Mellitus; Drug Evaluation; Gliclazide; Glyburide; Humans; Hypoglyce | 1990 |